TORONTO, Oct. 19, 2020 /CNW/ - NeuPath Health Inc. (TSX-V:NPTH) (formerly Klinik Health Ventures Corp.) ("NeuPath" or the "Company"), Canada's largest provider of chronic pain management services, is pleased to announce that it has entered into an agreement with Stifel GMP as co-lead underwriter and sole bookrunner and INFOR Financial Inc. as co-lead underwriter, together with a syndicate of underwriters including Haywood Securities Inc. (collectively, the "Underwriters"), which have agreed to purchase, on a "bought deal" basis 8,890,000 units (the "Units") of the Company at a price of $0.90 per Unit, for aggregate gross proceeds of $8,001,000. The Underwriters will also have the option, exercisable in whole or in part at any time on or up to 30 days after the closing of the offering, to purchase up to an additional 1,333,500 Units. In the event that the option is exercised in its entirety, the aggregate gross proceeds of the offering will be $9,201,150.

Each Unit will be comprised of one common share of the Company (a "Common Share") and onehalf of one Common Share purchase warrant (each whole Common Share purchase warrant, a "Warrant"). Each Warrant will be exercisable to acquire one Common Share (a "Warrant Share") for a period of 24 months following the closing of the Offering (the "Closing") at an exercise price of$1.25 per Warrant Share.

Click here to see the full PDF Press Release.